Amphora Medical Inc. closed a series B financing round for $35.5 million, led by Longitude Capital and Boston Scientific Corp. The Minneapolis, Minn.-based company will apply the funding to a trial for its Selective Bladder Denervation System among women with overactive bladder (OAB). Read More
